Follow us on:

Linkedin Facebook

Quest Diagnostics Incorporated – Consensus Indicates Potential -4.9% Downside

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Quest Diagnostics Incorporated found using ticker (DGX) now have 14 analysts covering the stock. The analyst consensus points to a rating of ‘Hold’. The target price ranges between 160 and 125 with the average target price sitting at 143.07. Given that the stocks previous close was at 150.46 this indicates there is a potential downside of -4.9%. The 50 day MA is 138.59 while the 200 day moving average is 135.91. The market capitalisation for the company is $16,960m. Find out more information at: https://www.questdiagnostics.com

The potential market cap would be $16,127m based on the market concensus.

0

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Latest Company News

    Broker Ratings

    Quest Diagnostics Incorporated – Consensus ‘hold’ rating and 12.1% Upside Potential

    Broker Ratings

    Quest Diagnostics Incorporated – Consensus ‘hold’ rating and 11.5% Upside Potential

    Broker Ratings

    Quest Diagnostics Incorporated – Consensus ‘Hold’ rating and 5.7% Upside Potential

    Broker Ratings

    Quest Diagnostics Incorporated – Consensus ‘Hold’ rating and 5.4% Upside Potential

    Broker Ratings

    Quest Diagnostics Incorporated – Consensus ‘Hold’ rating and 5.6% Upside Potential

    Broker Ratings

    Quest Diagnostics Incorporated – Consensus Indicates Potential 12.6% Upside

      Latest interviews

      View all interviews 

      Company Presentations

      View all Company Presentations

      Brokers Talk

      View all Broker Talk

      FTSE 100 News

      Search

      Search

      Green News

      View all Sustainable sectors, Plcs and news  

      Q&A's

      View all Question and Answers

      Funds

      View all Funds, Market Insights and news

      UK Broker Ratings

      Hardman & Co

      Don't Miss Our News Alerts

      Subscribe Free

      Find us on:

      Linkedin Facebook

      Useful links

      Disclaimer

      You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

      © 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.